GenLight

Genlight Neurotech, founded in Hangzhou in 2020, is a high-tech platform enterprise focused on industrializing cutting-edge technologies in the fields of brain science and neurosurgery. Its research and management are led by high-level overseas returnee talents. The company has built two advanced technology platforms: brain-computer modulation and Glaser high-end medical lasers, providing innovative medical device solutions for various neurological disorders. Products developed include a magnetic resonance-guided laser ablation surgical system for minimally invasive brain surgeries, and an implantable closed-loop self-responsive neurostimulation system for treating epilepsy, Parkinson's disease, and depression. Some of these products have entered formal clinical trial stages. Additionally, the company independently develops scientific research instruments and consumables to meet the needs of neuroscience experiments, offering integrated solutions for neuroscience laboratories. Currently, Genlight Neurotech employs approximately 170 staff members, with R&D and office space covering about 3,000 square meters, as well as GMP-standard production facilities spanning around 1,300 square meters. The company has applied for and obtained more than 160 patents. Adhering to the development philosophy of independent innovation and benefiting patients, Genlight Neurotech is committed to becoming a trusted leader in solutions for the field of neurology.